Ewing Sarcoma Breakpoint Region 1 (EWSR1) (C-Term) Peptide
EWSR1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5511158
Aperçu rapide pour Ewing Sarcoma Breakpoint Region 1 (EWSR1) (C-Term) Peptide (ABIN5511158)
Antigène
EWSR1
(Ewing Sarcoma Breakpoint Region 1 (EWSR1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Séquence
- SQQNTYGQPS SYGQQSSYGQ QSSYGQQPPT SYPPQTGSYS QAPSQYSQQS
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-EWSR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
-
Sujet
-
EWSR1 is a putative RNA binding protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors.
Protein Size: 354 -
ID gène
- 2130
Antigène
-
Vous êtes ici:
